Article Details

Stealth BioTherapeutics (NASDAQ:MITO) Price Target Cut to $1.50 by Analysts at HC Wainwright

Retrieved on: 2022-05-23 11:42:42

Tags for this article:

Click the tags to see associated articles and topics

Stealth BioTherapeutics (NASDAQ:MITO) Price Target Cut to $1.50 by Analysts at HC Wainwright. View article details on hiswai:

Excerpt

Millennium Management LLC owned about 0.06% of Stealth BioTherapeutics at the end of the most recent quarter. 1.52% of the stock is owned by ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up